Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


August 03, 2015 7:50 PM ET

Healthcare Equipment and Supplies

Company Overview of Vermillion, Inc.

Executive Profile

Robert C. Bast Jr., M.D.

Former Member of Scientific Advisory Board, Vermillion, Inc.
AgeTotal Calculated CompensationThis person is connected to 0 Board Members in 0 different organizations across 2 different industries.

----

Background

Mr. Robert C. Bast Jr., M.D. serves as Vice President for Translational Research and the Harry Carothers Wiess Distinguished University Professor for Cancer Research at the University of Texas M.D. Anderson Cancer Center. Dr. Bast is responsible for facilitating coordination between laboratory investigators and clinicians to help link new discoveries with patient treatment. He is best known for developing the Ovarian Cancer (OC) 125 monoclonal antibody that led to the ...

Corporate Headquarters

Building III
Austin, Texas 78738

United States

Phone: 512-519-0400
Fax: 512-439-6980

Board Members Memberships

There is no Board Members Memberships data available.

Education

BA
Wesleyan University
MD
Harvard Medical School

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Gon-Emon Kurihara President and Representative Director
Jeol Ltd.
--
Russell Cummings Chief Executive Officer, Executive Director and Member of Investment Committee
Imperial Innovations Group plc
$403.0K
Christopher J. Moreau Chief Executive Officer, President and Non Independent Director
Miraculins Inc.
$216.7K
Rene A. Schena Chairman and Chief Executive Officer
Arrayit Corporation
$78.8K
Jan Groen Ph.D.Chief Executive Officer, President and Executive Director
MDxHealth SA
$491.1K
Compensation as of Fiscal Year --.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Vermillion, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.